Previous Close | $38.35 |
Intrinsic Value | $0.00 |
Upside potential | -100% |
Data is not available at this time.
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT) specializing in the healthcare sector, primarily focusing on skilled nursing facilities (SNFs) and assisted living facilities (ALFs). The company operates as a landlord, leasing properties to third-party operators under long-term, triple-net lease agreements, which transfer most operational responsibilities to tenants. This model provides stable, predictable cash flows while minimizing direct exposure to healthcare operational risks. Omega’s portfolio is geographically diversified across the U.S. and the U.K., with a concentration on high-quality operators in fragmented markets. The company’s market position is strengthened by its scale, with over 900 properties, and its focus on essential healthcare real estate, which benefits from demographic tailwinds such as an aging population. Omega’s strategy emphasizes selective acquisitions, proactive asset management, and maintaining strong tenant relationships to sustain occupancy and rental income. The REIT’s niche focus on post-acute care facilities differentiates it from broader healthcare REITs, though it faces regulatory and reimbursement risks inherent in the sector.
Omega reported revenue of $1.05 billion for FY 2024, reflecting its stable lease-based income model. Net income stood at $406.3 million, with diluted EPS of $1.55, demonstrating solid profitability. Operating cash flow of $749.4 million underscores the company’s ability to generate cash from its core operations, while negligible capital expenditures highlight the capital-light nature of its triple-net lease structure. The absence of significant capex aligns with its REIT model, which prioritizes income distribution over reinvestment.
The company’s earnings power is driven by its high-margin lease revenue, with minimal operational costs due to its triple-net lease agreements. Omega’s capital efficiency is evident in its ability to sustain dividends while managing a leveraged balance sheet. The REIT’s focus on long-term leases with escalations provides visibility into future cash flows, supporting consistent earnings. However, its reliance on external financing for growth could pressure margins in rising interest rate environments.
Omega maintains a leveraged balance sheet, with total debt of $4.84 billion against cash and equivalents of $518.3 million. The debt load is typical for REITs but requires careful management to maintain investment-grade credit ratings. The company’s liquidity position is adequate, supported by its operating cash flow and access to capital markets. However, high leverage could limit flexibility in adverse market conditions or tenant distress scenarios.
Omega’s growth is primarily driven by strategic acquisitions and lease escalations, with limited organic expansion opportunities. The company has a strong dividend track record, paying $2.68 per share in FY 2024, reflecting a high payout ratio typical of REITs. Dividend sustainability depends on stable tenant performance and manageable leverage. Demographic trends support long-term demand for its properties, but near-term growth may be tempered by regulatory and reimbursement pressures.
The market values Omega based on its dividend yield and the stability of its healthcare-focused real estate portfolio. Current valuation metrics reflect investor confidence in its ability to maintain payouts, though concerns about tenant credit quality and sector headwinds may weigh on multiples. The REIT’s performance is closely tied to interest rates and healthcare policy, which influence its cost of capital and tenant profitability.
Omega’s strategic advantages include its scale, sector specialization, and long-term lease structures, which provide revenue stability. The company is well-positioned to benefit from aging population trends, but must navigate regulatory risks and tenant financial health. The outlook remains cautiously optimistic, with growth likely to be incremental and dependent on disciplined capital allocation and tenant management. Near-term challenges include interest rate volatility and potential tenant defaults.
10-K filing, company investor relations
show cash flow forecast
Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
Revenue growth rate, % | NaN | |||||||||||||||||||||||||
Revenue, $ | NaN | |||||||||||||||||||||||||
Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
Total operating expenses, $m | NaN | |||||||||||||||||||||||||
Operating income, $m | NaN | |||||||||||||||||||||||||
EBITDA, $m | NaN | |||||||||||||||||||||||||
Interest expense (income), $m | NaN | |||||||||||||||||||||||||
Earnings before tax, $m | NaN | |||||||||||||||||||||||||
Tax expense, $m | NaN | |||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
Total assets, $m | NaN | |||||||||||||||||||||||||
Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
Average production assets, $m | NaN | |||||||||||||||||||||||||
Working capital, $m | NaN | |||||||||||||||||||||||||
Total debt, $m | NaN | |||||||||||||||||||||||||
Total liabilities, $m | NaN | |||||||||||||||||||||||||
Total equity, $m | NaN | |||||||||||||||||||||||||
Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
Net income, $m | NaN | |||||||||||||||||||||||||
Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
Funds from operations, $m | NaN | |||||||||||||||||||||||||
Change in working capital, $m | NaN | |||||||||||||||||||||||||
Cash from operations, $m | NaN | |||||||||||||||||||||||||
Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
New CAPEX, $m | NaN | |||||||||||||||||||||||||
Total CAPEX, $m | NaN | |||||||||||||||||||||||||
Free cash flow, $m | NaN | |||||||||||||||||||||||||
Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
Discount rate, % | NaN | |||||||||||||||||||||||||
PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
Current shareholders' claim on cash, % | NaN |